Verrica Pharmaceuticals announces presentation of positive data from new pooled analysis of...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 20, 2020 at 10:23 PM.

  1. #1 cafead, Jan 20, 2020 at 10:23 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Verrica Pharmaceuticals announced the presentation of positive data from a post-hoc pooled analysis of the pivotal Phase 3 CAMP trials evaluating the safety and efficacy of VP-102 (cantharidin 0.7% topical solution), Verrica’s lead product candidate for the treatment of molluscum contagiosum (molluscum).

    article source
     
    Quote

  2. #2 anonymous, Aug 17, 2020 at 2:57 PM
    anonymous

    anonymous Guest

    Who the hell would join this company. Run Run they ran every company in the ground. Look into it. Unethical leadership stay away.
     
    Quote
  3. #3 anonymous, Aug 19, 2020 at 5:33 PM
    anonymous

    anonymous Guest

    Look into the lawsuits against TW and TC. What a joke. Unethical losers and above posts is spot on. Ran aqua in the ground.
     
    Quote
Reply to Thread